The founding of Heyl Japan Co. Ltd. as the Japanese representative of HEYL, headquartered in Tokyo, took place on 26 August, 1983. The core competencies here are also mainly in sales and distribution of finished medicinal products for the Japanese market. The most commonly known product is RADIOGARDASE®, an antidote for the radioactive poisoning from cesium and thallium.